These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24027432)

  • 1. COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis.
    Shao J; Teng Y; Padia R; Hong S; Noh H; Xie X; Mumm JS; Dong Z; Ding HF; Cowell J; Kim J; Han J; Huang S
    Neoplasia; 2013 Sep; 15(9):1075-85. PubMed ID: 24027432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice.
    Migliorini D; Bogaerts S; Defever D; Vyas R; Denecker G; Radaelli E; Zwolinska A; Depaepe V; Hochepied T; Skarnes WC; Marine JC
    J Clin Invest; 2011 Apr; 121(4):1329-43. PubMed ID: 21403399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1.
    Savio MG; Rotondo G; Maglie S; Rossetti G; Bender JR; Pardi R
    Oncogene; 2008 Apr; 27(17):2401-11. PubMed ID: 17968316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
    Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC
    Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability.
    Su CH; Zhao R; Zhang F; Qu C; Chen B; Feng YH; Phan L; Chen J; Wang H; Wang H; Yeung SC; Lee MH
    Cancer Res; 2011 Feb; 71(3):884-94. PubMed ID: 21135113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the COP1 protein in cancer development and therapy.
    Song Y; Liu Y; Pan S; Xie S; Wang ZW; Zhu X
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):43-52. PubMed ID: 32027978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KAT6A, a novel regulator of β-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1.
    Liu W; Zhan Z; Zhang M; Sun B; Shi Q; Luo F; Zhang M; Zhang W; Hou Y; Xiao X; Li Y; Feng H
    Theranostics; 2021; 11(13):6278-6292. PubMed ID: 33995658
    [No Abstract]   [Full Text] [Related]  

  • 8. Constitutive photomorphogenesis protein 1 (COP1) and COP9 signalosome, evolutionarily conserved photomorphogenic proteins as possible targets of melatonin.
    Sanchez-Barcelo EJ; Mediavilla MD; Vriend J; Reiter RJ
    J Pineal Res; 2016 Aug; 61(1):41-51. PubMed ID: 27121162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E3 ligase COP1 promotes ERα signaling and suppresses EMT in breast cancer.
    Tang SC; Lion Q; Peulen O; Chariot P; Lavergne A; Mayer A; Fuster PA; Close P; Klein S; Florin A; Büttner R; Nemazanyy I; Shostak K; Chariot A
    Oncogene; 2022 Jan; 41(2):173-190. PubMed ID: 34716429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good COP1 or bad COP1? In vivo veritas.
    Wei W; Kaelin WG
    J Clin Invest; 2011 Apr; 121(4):1263-5. PubMed ID: 21403396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.
    Choi HH; Guma S; Fang L; Phan L; Ivan C; Baggerly K; Sood A; Lee MH
    Cell Cycle; 2015; 14(14):2265-73. PubMed ID: 25945542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions.
    Jiang Q; Zheng N; Bu L; Zhang X; Zhang X; Wu Y; Su Y; Wang L; Zhang X; Ren S; Dai X; Wu D; Xie W; Wei W; Zhu Y; Guo J
    Mol Cancer; 2021 Aug; 20(1):100. PubMed ID: 34353330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.
    Sarkar TR; Sharan S; Wang J; Pawar SA; Cantwell CA; Johnson PF; Morrison DK; Wang JM; Sterneck E
    Mol Cell Biol; 2012 Jan; 32(2):320-32. PubMed ID: 22037769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase 3β sustains invasion of glioblastoma via the focal adhesion kinase, Rac1, and c-Jun N-terminal kinase-mediated pathway.
    Chikano Y; Domoto T; Furuta T; Sabit H; Kitano-Tamura A; Pyko IV; Takino T; Sai Y; Hayashi Y; Sato H; Miyamoto K; Nakada M; Minamoto T
    Mol Cancer Ther; 2015 Feb; 14(2):564-74. PubMed ID: 25504636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
    Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
    Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spotlight on the role of COP1 in tumorigenesis.
    Marine JC
    Nat Rev Cancer; 2012 Jun; 12(7):455-64. PubMed ID: 22673153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.
    Lin X; Li AM; Li YH; Luo RC; Zou YJ; Liu YY; Liu C; Xie YY; Zuo S; Liu Z; Liu Z; Fang WY
    Signal Transduct Target Ther; 2020 Feb; 5(1):13. PubMed ID: 32296025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase.
    Pérez-Benavente B; García JL; Rodríguez MS; Pineda-Lucena A; Piechaczyk M; Font de Mora J; Farràs R
    Oncogene; 2013 Apr; 32(17):2189-99. PubMed ID: 22710716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase (GSK) 3β phosphorylates and protects nuclear myosin 1c from proteasome-mediated degradation to activate rDNA transcription in early G1 cells.
    Sarshad AA; Corcoran M; Al-Muzzaini B; Borgonovo-Brandter L; Von Euler A; Lamont D; Visa N; Percipalle P
    PLoS Genet; 2014 Jun; 10(6):e1004390. PubMed ID: 24901984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COP1 is a tumour suppressor that causes degradation of ETS transcription factors.
    Vitari AC; Leong KG; Newton K; Yee C; O'Rourke K; Liu J; Phu L; Vij R; Ferrando R; Couto SS; Mohan S; Pandita A; Hongo JA; Arnott D; Wertz IE; Gao WQ; French DM; Dixit VM
    Nature; 2011 May; 474(7351):403-6. PubMed ID: 21572435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.